​

Aileron Therapeutics Ownership | Who Owns Aileron Therapeutics?

OverviewForecastFinancialsChart

Aileron Therapeutics Ownership Summary

Aileron Therapeutics is owned by 0.65% insiders, and 99.35% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.90% of its assets in Aileron Therapeutics shares.

ALRN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAileron Therapeutics-0.65%99.35%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241-213--14738.46%--100.00%--
Jun 30, 20241-213---1---
Sep 30, 202228-17.65%28,290,891-11.81%312.50%11-4-42.86%
Jun 30, 202234-12.82%32,080,815-0.38%352.80%11-7-41.67%
Mar 31, 202239-4.88%32,202,779-4.04%352.49%11-47.62%1250.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr412.22K1.90%-
Vanguard Total Stock Mkt Idx Inv289.44K1.34%289.44K
Fidelity Extended Market Index108.00K0.50%-1.64K
iShares Micro-Cap ETF45.54K0.21%-
Fidelity Total Market Index35.68K0.16%-
Fidelity Series Total Market Index25.11K0.12%-
Northern Trust Extended Eq Market Idx21.13K0.10%-
NT Ext Equity Mkt Idx Fd - L21.13K0.10%-
Vanguard U.S. Eq Idx £ Acc12.77K0.06%-
Spartan Total Market Index Pool E11.46K0.05%153.00

Recent Insider Transactions

DateNameRoleActivityValue
Dec 05, 2024WINDSOR JAMES BRIAN President and CEOBuy$535.36
Dec 05, 2024WINDSOR JAMES BRIAN President and CEOBuy$362.25
Jun 14, 2024UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO-Sell$6.27K
Jun 17, 2024UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO-Sell$15.30K
Jun 11, 2024UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO-Sell$1.68K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2-52
2024 Q1--
2023 Q42-

ALRN Ownership FAQ

Who Owns Aileron Therapeutics?

Aileron Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 0.65% insiders and 99.35% retail investors. The average institutional ownership in Aileron Therapeutics's industry, Biotech Stocks , is 68.48%, which Aileron Therapeutics falls below.

Does Blackrock own Aileron Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aileron Therapeutics.

Who is the top mutual fund holder of Aileron Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Aileron Therapeutics shares, with 1.90% of its total shares outstanding invested in 412.22K Aileron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools